Skip to main content
. 2018 Aug 14;17:113. doi: 10.1186/s12933-018-0756-2

Table 2.

Echocardiographic results in patients at baseline and at the 4-year follow-up examination, and in controls

Patients, n Patients baseline Patients follow-up p-value
Patients baseline vs. follow-up
Controls, n Controls baseline p-value
Patients baseline vs. controls
LA, mm/m2 380 20.4 (3.1) 20.6 (3.1) ns 183 20.8 (4.0) ns
LVEDV, mL/m2 371 46.1 (13.1) 46.5 (12.0) < 0.05 180 48.8 (11.3) < 0.01
LV mass, g/m2 324 101.8 (30.3) 101.7 (26.9) ns 174 94.5 (29.9) < 0.001
LVEF, % 370 52.0 (10.5) 53.0 (11.0) ns 180 57.0 (9.0) < 0.001
MAPSE, mm 370 12.0 (2.0) 12.0 (2.0) ns 184 12.3 (2.3) ns
E/é 378 11.9 (4.5) 13.3 (4.9) < 0.001 183 10.3 (4.1) < 0.001

Data are presented as median and (interquartile range)

LA LVEDV and LV mass are indexed by body surface area, ns not significant, LA left atrium, LVEDV left ventricular end-diastolic volume, LV left ventricle, LVEF left ventricular ejection fraction, MAPSE mitral annular plane systolic excursion, E transmitral E-wave velocity, early diastolic mitral annulus velocity